Twelve academic and private clinical sites across the U.S. broaden patient access to the pivotal trial as Femasys advances ...
FemaSeed is creating a new opportunity for OB/GYNs to provide first-line fertility treatment in their own practices, bringing care historically performed primarily by infertility specialists into a ...
ATLANTA, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to ...
Hosted on MSN
Wanting to be child-free, these women got fallopian tube removal. The surgery may also cut ovarian cancer risk
Franziska Bohm long knew she didn't want kids and asked her family doctor to have her tubes tied, known officially as tubal ligation. At 28, she had her fallopian tubes removed after the surgeon ...
Many women spend decades using birth control of one kind or another, except for when they’re trying to conceive or are pregnant. So when you know you’re done having babies or if you plan to stay child ...
Femasys Inc. announced the achievement of CE mark certification for the FemBloc delivery system, marking it as the first regulatory approval in the world for a non-surgical permanent birth control ...
When the Supreme Court overturned the national right to abortion in June 2022, some friends and family of Jacqueline Ellison (SPH’20) underwent or considered “permanent contraception”—vasectomies and ...
The Essure system, now owned by Bayer after it acquired Conceptus in 2013, is intended to provide non-surgical permanent birth control. The Essure nickel-titanium alloy inserts, which look like small ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results